BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20615931)

  • 1. High-dose glycine impairs the prepulse inhibition measure of sensorimotor gating in humans.
    O'Neill BV; Croft RJ; Mann C; Dang O; Leung S; Galloway MP; Phan KL; Nathan PJ
    J Psychopharmacol; 2011 Dec; 25(12):1632-8. PubMed ID: 20615931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information processing.
    Klamer D; Svensson L; Fejgin K; Pålsson E
    Eur Neuropsychopharmacol; 2011 Mar; 21(3):248-53. PubMed ID: 21111580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cognitive effects of modulating the glycine site of the NMDA receptor with high-dose glycine in healthy controls.
    Palmer C; Ellis KA; O'Neill BV; Croft RJ; Leung S; Oliver C; Wesnes KA; Nathan PJ
    Hum Psychopharmacol; 2008 Mar; 23(2):151-9. PubMed ID: 17972276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of sertindole on sensory gating, sensorimotor gating, and cognition in healthy volunteers.
    Holstein DH; Csomor PA; Geyer MA; Huber T; Brugger N; Studerus E; Vollenweider FX
    J Psychopharmacol; 2011 Dec; 25(12):1600-13. PubMed ID: 21890590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively.
    Riba J; Rodríguez-Fornells A; Barbanoj MJ
    Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers.
    Oranje B; Wienberg M; Glenthoj BY
    Psychiatry Res; 2011 Apr; 186(2-3):431-6. PubMed ID: 20971512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels.
    Vollenweider FX; Barro M; Csomor PA; Feldon J
    Biol Psychiatry; 2006 Sep; 60(6):597-603. PubMed ID: 16997001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating sensorimotor gating in healthy volunteers: the effects of desipramine and haloperidol.
    Oranje B; Kahn RS; Kemner C; Verbaten MN
    Psychiatry Res; 2004 Jul; 127(3):195-205. PubMed ID: 15296819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the PCP analog dizocilpine on sensory gating: potential relevance to clinical subtypes of schizophrenia.
    al-Amin HA; Schwarzkopf SB
    Biol Psychiatry; 1996 Oct; 40(8):744-54. PubMed ID: 8894067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustic startle response and sensorimotor gating in a genetic mouse model for the Y1 receptor.
    Karl T; Chesworth R; Duffy L; Herzog H
    Neuropeptides; 2010 Jun; 44(3):233-9. PubMed ID: 20096928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
    Heekeren K; Neukirch A; Daumann J; Stoll M; Obradovic M; Kovar KA; Geyer MA; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2007 May; 21(3):312-20. PubMed ID: 17591658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol rapidly disrupts prepulse inhibition in healthy men.
    Richter S; Schulz A; Zech CM; Oitzl MS; Daskalakis NP; Blumenthal TD; Schächinger H
    Psychoneuroendocrinology; 2011 Jan; 36(1):109-14. PubMed ID: 20685043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis.
    Swerdlow NR; Bhakta S; Chou HH; Talledo JA; Balvaneda B; Light GA
    Neuropsychopharmacology; 2016 Jan; 41(2):419-30. PubMed ID: 26062785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function.
    Duncan GE; Moy SS; Perez A; Eddy DM; Zinzow WM; Lieberman JA; Snouwaert JN; Koller BH
    Behav Brain Res; 2004 Aug; 153(2):507-19. PubMed ID: 15265649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences and hormonal influences in human sensorimotor gating: implications for schizophrenia.
    Kumari V
    Curr Top Behav Neurosci; 2011; 8():141-54. PubMed ID: 21374020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary and secondary neural networks of auditory prepulse inhibition: a functional magnetic resonance imaging study of sensorimotor gating of the human acoustic startle response.
    Campbell LE; Hughes M; Budd TW; Cooper G; Fulham WR; Karayanidis F; Hanlon MC; Stojanov W; Johnston P; Case V; Schall U
    Eur J Neurosci; 2007 Oct; 26(8):2327-33. PubMed ID: 17908169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct forms of prepulse inhibition disruption distinguishable by the associated changes in prepulse-elicited reaction.
    Yee BK; Feldon J
    Behav Brain Res; 2009 Dec; 204(2):387-95. PubMed ID: 19114060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of prepulse inhibition and increases in locomotor activity by competitive N-methyl-D-aspartate receptor antagonists in rats.
    Bakshi VP; Tricklebank M; Neijt HC; Lehmann-Masten V; Geyer MA
    J Pharmacol Exp Ther; 1999 Feb; 288(2):643-52. PubMed ID: 9918570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies.
    Swerdlow NR; Eastvold A; Karban B; Ploum Y; Stephany N; Geyer MA; Cadenhead K; Auerbach PP
    Psychopharmacology (Berl); 2002 May; 161(2):189-201. PubMed ID: 11981599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in mice.
    Liu X; Hong SI; Park SJ; Dela Peña JB; Che H; Yoon SY; Kim DH; Kim JM; Cai M; Risbrough V; Geyer MA; Shin CY; Cheong JH; Park H; Lew JH; Ryu JH
    Arch Pharm Res; 2013 Jul; 36(7):854-63. PubMed ID: 23543630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.